Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Congress on Controversies in Ophthalmology (COPHy)

Congress on Controversies in Ophthalmology (COPHy)
Web Address: COPHy Website

We take great pleasure in inviting you to the 16th Annual Congress on Controversies in Ophthalmology (COPHy 2025) which will take place on April 4-5, 2025 in Seville, Spain.

Following in the footsteps of COPHy’s long-standing tradition, COPHy 2025 will once again strive to maintain the highest of standards and, as in the past, will continue to focus on the debates concerning controversial issues in ophthalmology, the core of the congress.

The meeting will focus on innovations and controversies in retina, but also will have featured sessions on uveitis, neuro-ophthalmology, and glaucoma.  Leading world experts will present two opposed approaches to controversial issues. Each topic presented will be followed by a live discussion of ophthalmologists experienced in the area being discussed.

Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date recommendations to ongoing debates even when data remains limited, through evidence-based medicine, including expert opinion. Participants will have the opportunity to take part in this vibrant meeting which will facilitate discussions on the shared experiences and opinions of leading local and international experts.

Get ready to listen to exciting debates by experts who are not afraid to take on controversial hot topics and who are willing to share their knowledge.

Further Resources

Close Popup